A new research paper was published in Volume 12 of Oncoscience on October 14, 2025, titled "Bridging clinical insight and laboratory model in high-grade serous ovarian carcinoma (HGSOC) using DNA sequencing-based profiling of TP53." Read more
Medical News - Dec 24
The giant health care company said it would appeal the jury’s liability verdict and compensatory damages. Read more
New York Post - Dec 13
CNN’s chief international anchor Christiane Amanpour revealed on Thursday that her battle against ovarian cancer is back on after the disease returned for a third time. Read more
Spokesman - Oct 25
After a month off the air, the veteran journalist disclosed that the disease had returned in what doctors described as a "fairly rare" form. Read more
New York Post - Oct 24
The American Cancer Society estimates a woman's risk of getting ovarian cancer is about 1 in 91. Read more
Abc 30 - Oct 22
Story of Maya Ortiz who was diagnosed with Stage 3 Ovarian Cancer at age 18. Experts weigh in on how this disease presents, is diagnosed, and managed. Read more
Forbes - Oct 21
'This is the hardest part of my life that I have ever had to share,' the '90 Day' alum says. Read more
Showbiz Cheatsheet - Sep 30
University College London Hospitals NHS Foundation Trust (UCLH) is offering surveillance tests to women with the BRCA1 or BRCA2 gene mutations that put them at higher risk of the disease. Read more
Mail Online - Sep 29
The new test can dramatically cut the chance of being diagnosed with late-stage ovarian cancer Read more
The Independent - Sep 29
A new research paper was published in Volume 16 of Oncotarget on September 22, 2025, titled "Loss of Trp53 results in a hypoactive T cell phenotype accompanied by reduced pro-inflammatory signaling in a syngeneic orthotopic mouse model of ovarian high-grade serous carcinoma." Read more
Medical News - Sep 25
